Venture NAV Tracker / Fund
Horizon Technology Finance Corp (HRZN)
Filed schedule as of 2026-06-30
Structureventure debt BDC
ExchangeNASDAQ
NAV / share$6.23Jun 30, 2026 · source ↗
Market price$4.49Oct 7, 2026 · source ↗
Premium / discount-27.9%Derived from latest filed NAV per share and market price
Net assets$417.5MJun 30, 2026 · source ↗
Latest observation
NAV vs. market price
Each figure carries its own reporting date.
Schedule of investments
Debt investments
Jun 30, 2026 reporting period
| Company | Security type | Principal | Cost | Fair value | FV / principal | Rate | Maturity | Non-accrual | Source |
|---|---|---|---|---|---|---|---|---|---|
| Kodiak Robotics, Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $15M | $14.6M | $14.6M | 97.7% | Cash rate 10.25%; Index Prime; Margin 3.50%; Floor 10.00%; ETP 4.00% | Jan 1, 2030 | — | Filing ↗ |
| Ossio, Inc.Medical Device | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $12.6M | $12.4M | $12.4M | 98.6% | Cash rate 10.00%; Index Prime; Margin 3.25%; Floor 3.25%; ETP 3.00% | Jan 20, 2031 | — | Filing ↗ |
| Long Grove Pharmaceuticals, LLCBiotechnology | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $10.5M | $10.3M | $10.5M | 100.7% | Cash rate 11.62%; Index 1-month SOFR; Margin 4.00%; Floor 6.00% | Feb 27, 2031 | — | Filing ↗ |
| Castle Creek Biosciences, Inc.Biotechnology | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $10M | $10M | $10M | 99.6% | Cash rate 12.00%; Index Prime; Margin 4.25%; Floor 12.00%; ETP 4.00% | Mar 1, 2028 | — | Filing ↗ |
| Elligo Health Research, Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $10M | $9.9M | $9.9M | 99.1% | Cash rate 11.75%; Index Prime; Margin 3.50%; Floor 11.75%; ETP 6.00% | Oct 1, 2027 | — | Filing ↗ |
| Onkos Surgical, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $10M | $9.9M | $9.9M | 98.9% | Cash rate 10.75%; Index Prime; Margin 3.25%; Floor 10.75%; ETP 4.00% | Jan 1, 2030 | — | Filing ↗ |
| Onkos Surgical, Inc.Medical Device | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $10M | $9.9M | $9.9M | 98.9% | Cash rate 10.75%; Index Prime; Margin 3.25%; Floor 10.75%; ETP 4.00% | Jan 1, 2030 | — | Filing ↗ |
| Sonex Health, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $10M | $9.9M | $9.9M | 98.6% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 11.75%; ETP 5.00% | Apr 1, 2030 | — | Filing ↗ |
| Samba TV, Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $10.1M | $9.9M | $9.9M | 97.9% | Cash rate 10.25%; Index Prime; Margin 3.50%; Floor 3.50%; ETP 4.00% | Dec 1, 2030 | — | Filing ↗ |
| BriteCore Holdings, Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $10M | $9.8M | $9.8M | 98.4% | Cash rate 10.50%; Index Prime; Margin 3.75%; Floor 10.25%; ETP 3.00% | Jan 1, 2031 | — | Filing ↗ |
| Pelthos Therapeutics, Inc.Biotechnology | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $10M | $9.8M | $9.8M | 98.0% | Cash rate 10.50%; Index Prime; Margin 3.75%; Floor 10.50%; ETP 5.00% | Jan 31, 2031 | — | Filing ↗ |
| Pelthos Therapeutics, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $10M | $9.8M | $9.8M | 98.0% | Cash rate 10.50%; Index Prime; Margin 3.75%; Floor 10.50%; ETP 5.00% | Jan 31, 2031 | — | Filing ↗ |
| Sonex Health, Inc.Medical Device | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $10M | $9.8M | $9.8M | 97.6% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 11.75%; ETP 5.00% | Apr 1, 2030 | — | Filing ↗ |
| Ossio, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $7.6M | $7.5M | $7.5M | 98.6% | Cash rate 10.00%; Index Prime; Margin 3.25%; Floor 3.25%; ETP 3.00% | Jan 20, 2031 | — | Filing ↗ |
| Samba TV, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $7.5M | $7.4M | $7.4M | 98.7% | Cash rate 10.25%; Index Prime; Margin 3.50%; Floor 3.50%; ETP 4.00% | Dec 1, 2030 | — | Filing ↗ |
| MasteryPrep, LLC | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $7.5M | $7.4M | $7.4M | 99.2% | Cash rate 11.50%; Index Prime; Margin 4.00%; Floor 11.50%; ETP 3.75% | Jul 1, 2029 | — | Filing ↗ |
| GT Medical Technologies, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $7.5M | $7.4M | $7.4M | 98.9% | Cash rate 11.25%; Index Prime; Margin 3.25%; Floor 11.25%; ETP 4.00% | Oct 1, 2029 | — | Filing ↗ |
| BriteCore Holdings, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $7.5M | $7.4M | $7.4M | 98.9% | Cash rate 10.50%; Index Prime; Margin 3.75%; Floor 10.25%; ETP 3.00% | Jan 1, 2031 | — | Filing ↗ |
| MasteryPrep, LLCSoftware | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $7.5M | $7.4M | $7.4M | 98.9% | Cash rate 11.50%; Index Prime; Margin 4.00%; Floor 11.50%; ETP 3.75% | Jul 1, 2029 | — | Filing ↗ |
| Kodiak Robotics, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $7.5M | $7.3M | $7.3M | 97.7% | Cash rate 10.25%; Index Prime; Margin 3.50%; Floor 10.00%; ETP 4.00% | Jan 1, 2030 | — | Filing ↗ |
| Kodiak Robotics, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $7.5M | $7.3M | $7.3M | 97.7% | Cash rate 10.25%; Index Prime; Margin 3.50%; Floor 10.00%; ETP 4.00% | Jan 1, 2030 | — | Filing ↗ |
| Hound Labs II, LLCDiagnostics | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $7.2M | $7.2M | $6.7M | 93.3% | Cash rate 12.75%; Index Prime; Margin 6.00%; Floor 9.25% | Jul 1, 2027 | — | Filing ↗ |
| Castle Creek Biosciences, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5.5M | $5.5M | $5.5M | 99.6% | Cash rate 12.00%; Index Prime; Margin 4.25%; Floor 12.00%; ETP 4.00% | Mar 1, 2028 | — | Filing ↗ |
| Dropoff, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $9.2M | $9.2M | $5.4M | 58.8% | Cash rate 13.25%; Index Prime; Margin 6.50%; Floor 9.75%; ETP 3.50% | Jun 30, 2028 | — | Filing ↗ |
| MML US, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5.2M | $5.2M | $5.2M | 99.3% | Cash rate 10.00%; Index Prime; Margin 3.00%; Floor 10.00%; Ceiling 13.50%; ETP 3.00% | Mar 1, 2030 | — | Filing ↗ |
| MML US, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5.2M | $5.2M | $5.2M | 99.3% | Cash rate 10.00%; Index Prime; Margin 3.00%; Floor 10.00%; Ceiling 13.50%; ETP 3.00% | Mar 1, 2030 | — | Filing ↗ |
| MML US, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5.2M | $5.1M | $5.1M | 99.2% | Cash rate 10.00%; Index Prime; Margin 3.00%; Floor 10.00%; Ceiling 13.50%; ETP 3.00% | Mar 1, 2030 | — | Filing ↗ |
| MML US, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5.2M | $5.1M | $5.1M | 99.2% | Cash rate 10.00%; Index Prime; Margin 3.00%; Floor 10.00%; Ceiling 13.50%; ETP 3.00% | Mar 1, 2030 | — | Filing ↗ |
| Shengrow, Inc. aka Soli Organic, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Revolver | $5M | $5M | $5M | 100.0% | Cash rate 12.75%; Index Prime; Margin 6.00%; Floor 9.75% | Mar 31, 2027 | — | Filing ↗ |
| Shengrow, Inc. aka Soli Organic, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Revolver | $5M | $4.2M | $5M | 100.0% | Cash rate 12.75%; Index Prime; Margin 6.00%; Floor 9.75% | Mar 31, 2027 | — | Filing ↗ |
| Castle Creek Biosciences, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $5M | 99.6% | Cash rate 12.00%; Index Prime; Margin 4.25%; Floor 12.00%; ETP 4.00% | Mar 1, 2028 | — | Filing ↗ |
| Castle Creek Biosciences, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $5M | 99.6% | Cash rate 12.00%; Index Prime; Margin 4.25%; Floor 12.00%; ETP 4.00% | Mar 1, 2028 | — | Filing ↗ |
| Samba TV, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $5M | 98.7% | Cash rate 10.25%; Index Prime; Margin 3.50%; Floor 3.50%; ETP 4.00% | Dec 1, 2030 | — | Filing ↗ |
| Ceribell, Inc.Medical Device | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $5M | 99.2% | Cash rate 9.50%; Index Prime; Margin 2.75%; Floor 9.25%; ETP 4.00% | Mar 1, 2029 | — | Filing ↗ |
| Elligo Health Research, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $5M | 99.1% | Cash rate 11.75%; Index Prime; Margin 3.50%; Floor 11.75%; ETP 6.00% | Oct 1, 2027 | — | Filing ↗ |
| Elligo Health Research, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $5M | 99.1% | Cash rate 11.75%; Index Prime; Margin 3.50%; Floor 11.75%; ETP 6.00% | Oct 1, 2027 | — | Filing ↗ |
| Elligo Health Research, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $5M | 99.1% | Cash rate 11.75%; Index Prime; Margin 3.50%; Floor 11.75%; ETP 6.00% | Oct 1, 2027 | — | Filing ↗ |
| MML US, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $5M | 99.0% | Cash rate 10.00%; Index Prime; Margin 3.00%; Floor 10.00%; Ceiling 13.50%; ETP 3.00% | Mar 1, 2030 | — | Filing ↗ |
| MML US, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $5M | 99.0% | Cash rate 10.00%; Index Prime; Margin 3.00%; Floor 10.00%; Ceiling 13.50%; ETP 3.00% | Mar 1, 2030 | — | Filing ↗ |
| HiveMQ Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $5M | 99.0% | Cash rate 11.00%; Index Prime; Margin 4.25%; Floor 10.50%; ETP 9.00% | Jul 1, 2031 | — | Filing ↗ |
| HiveMQ Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $5M | 99.0% | Cash rate 11.00%; Index Prime; Margin 4.25%; Floor 10.50%; ETP 9.00% | Jul 1, 2031 | — | Filing ↗ |
| HiveMQ Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $5M | 99.0% | Cash rate 11.00%; Index Prime; Margin 4.25%; Floor 10.50%; ETP 9.00% | Jul 1, 2031 | — | Filing ↗ |
| HiveMQ Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $5M | 99.0% | Cash rate 11.00%; Index Prime; Margin 4.25%; Floor 10.50%; ETP 9.00% | Jul 1, 2031 | — | Filing ↗ |
| Spineology, Inc.Medical Device | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.9% | Cash rate 12.00%; Index Prime; Margin 5.00%; Floor 12.00%; ETP 1.00% | Aug 1, 2029 | — | Filing ↗ |
| Infobionic, Inc.Medical Device | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.9% | Cash rate 12.00%; Index Prime; Margin 4.50%; Floor 12.00%; ETP 2.00% | Sep 1, 2029 | — | Filing ↗ |
| Infobionic, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.9% | Cash rate 12.00%; Index Prime; Margin 4.50%; Floor 12.00%; ETP 2.00% | Sep 1, 2029 | — | Filing ↗ |
| Infobionic, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.9% | Cash rate 12.00%; Index Prime; Margin 4.50%; Floor 12.00%; ETP 2.00% | Sep 1, 2029 | — | Filing ↗ |
| Onkos Surgical, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.9% | Cash rate 10.75%; Index Prime; Margin 3.25%; Floor 10.75%; ETP 4.00% | Jan 1, 2030 | — | Filing ↗ |
| Onkos Surgical, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.9% | Cash rate 10.75%; Index Prime; Margin 3.25%; Floor 10.75%; ETP 4.00% | Jan 1, 2030 | — | Filing ↗ |
| Crafty Holdings, Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.9% | Cash rate 12.00%; Index Prime; Margin 4.50%; Floor 12.00%; ETP 4.00% | Jan 1, 2029 | — | Filing ↗ |
| Crafty Holdings, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.9% | Cash rate 12.00%; Index Prime; Margin 4.50%; Floor 12.00%; ETP 4.00% | Jan 1, 2029 | — | Filing ↗ |
| Crafty Holdings, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.9% | Cash rate 12.00%; Index Prime; Margin 4.50%; Floor 12.00%; ETP 4.00% | Jan 1, 2029 | — | Filing ↗ |
| Stellar Cyber, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.8% | Cash rate 10.50%; Index Prime; Margin 3.75%; Floor 10.50%; ETP 4.00% | Apr 1, 2030 | — | Filing ↗ |
| Stellar Cyber, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.8% | Cash rate 10.50%; Index Prime; Margin 3.75%; Floor 10.50%; ETP 4.00% | Apr 1, 2030 | — | Filing ↗ |
| Phigenics Holdings, Inc.Other Sustainability | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.7% | Cash rate 8.89%; Index 1-month SOFR; Margin 5.25%; Floor 6.25% | Jun 18, 2032 | — | Filing ↗ |
| Glass Routes, LLC.Communications | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $4.9M | $4.9M | $4.9M | 100.0% | 11.16% | May 15, 2028 | — | Filing ↗ |
| Onkos Surgical, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.7% | Cash rate 10.75%; Index Prime; Margin 3.25%; Floor 10.75%; ETP 4.00% | Oct 1, 2030 | — | Filing ↗ |
| Avive Solutions, Inc.Medical Device | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.6% | Cash rate 9.75%; Index Prime; Margin 3.00%; Floor 9.50%; ETP 3.00% | Apr 1, 2031 | — | Filing ↗ |
| Avive Solutions, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.6% | Cash rate 9.75%; Index Prime; Margin 3.00%; Floor 9.50%; ETP 3.00% | Apr 1, 2031 | — | Filing ↗ |
| Apkudo, Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.4% | Cash rate 11.25%; Index Prime; Margin 4.25%; Floor 11.25%; ETP 3.00% | Oct 1, 2029 | — | Filing ↗ |
| Apkudo, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.4% | Cash rate 11.25%; Index Prime; Margin 4.25%; Floor 11.25%; ETP 3.00% | Oct 1, 2029 | — | Filing ↗ |
| Hyperfine, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.2% | Cash rate 11.00%; Index Prime; Margin 4.25%; Floor 10.75%; ETP 5.00% | Mar 18, 2031 | — | Filing ↗ |
| Hyperfine, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.2% | Cash rate 11.00%; Index Prime; Margin 4.25%; Floor 10.75%; ETP 5.00% | Mar 18, 2031 | — | Filing ↗ |
| Pelthos Therapeutics, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.0% | Cash rate 10.50%; Index Prime; Margin 3.75%; Floor 10.50%; ETP 5.00% | Jan 31, 2031 | — | Filing ↗ |
| Pelthos Therapeutics, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.9M | $4.9M | 98.0% | Cash rate 10.50%; Index Prime; Margin 3.75%; Floor 10.50%; ETP 5.00% | Jan 31, 2031 | — | Filing ↗ |
| Ceribell, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $4M | $4.9M | $4.9M | 122.0% | Cash rate 9.50%; Index Prime; Margin 2.75%; Floor 9.25%; ETP 4.00% | Mar 1, 2029 | — | Filing ↗ |
| Stellar Cyber, Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.8M | $4.8M | 96.8% | Cash rate 10.50%; Index Prime; Margin 3.75%; Floor 10.50%; ETP 4.00% | Apr 1, 2030 | — | Filing ↗ |
| HiveMQ Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.8M | $4.8M | 96.0% | Cash rate 11.00%; Index Prime; Margin 4.25%; Floor 10.50%; ETP 9.00% | Jul 1, 2031 | — | Filing ↗ |
| BrightInsight, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $6.4M | $6.4M | $4.8M | 74.6% | Cash rate 12.50%; Index Prime; Margin 5.50%; Floor 9.50%; ETP 4.00% | Aug 1, 2027 | — | Filing ↗ |
| Dropoff, Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan (17) | $8.1M | $2.7M | $4.8M | 58.8% | Cash rate 13.25%; Index Prime; Margin 6.50%; Floor 9.75%; ETP 3.50% | Jun 30, 2028 | — | Filing ↗ |
| Hyperfine, Inc.Medical Device | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4.6M | $4.6M | 92.3% | Cash rate 11.00%; Index Prime; Margin 4.25%; Floor 10.75%; ETP 5.00% | Mar 18, 2031 | — | Filing ↗ |
| Supply Network Visibility Holdings LLC | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $4.6M | 91.3% | Cash rate 12.00%; Index Prime; Margin 4.25%; Floor 12.00%; ETP 2.50% | Jul 1, 2029 | — | Filing ↗ |
| Spineology, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $4.3M | $4.2M | $4.2M | 98.9% | Cash rate 12.00%; Index Prime; Margin 5.00%; Floor 12.00%; ETP 1.00% | Aug 1, 2029 | — | Filing ↗ |
| Spineology, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $4.3M | $4.2M | $4.2M | 98.9% | Cash rate 12.00%; Index Prime; Margin 5.00%; Floor 12.00%; ETP 1.00% | Aug 1, 2029 | — | Filing ↗ |
| BrightInsight, Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan (17) | $5.5M | $2.9M | $4.1M | 74.7% | Cash rate 12.50%; Index Prime; Margin 5.50%; Floor 9.50%; ETP 4.00% | Aug 1, 2027 | — | Filing ↗ |
| Volt Bidco, Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $4M | $3.9M | $4M | 100.0% | Cash rate 8.91%; Index 3-monthSOFR; Margin 5.25%; Floor 6.00% | Apr 30, 2032 | — | Filing ↗ |
| Ceribell, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $4M | $4M | 79.4% | Cash rate 9.50%; Index Prime; Margin 2.75%; Floor 9.25%; ETP 4.00% | Mar 1, 2029 | — | Filing ↗ |
| Mirantis, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.8M | $3.7M | $3.7M | 99.2% | Cash rate 11.75%; Index Prime; Margin 3.50%; Floor 11.75%; ETP 4.00% | Oct 1, 2028 | — | Filing ↗ |
| Mirantis, Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.8M | $3.7M | $3.7M | 99.2% | Cash rate 11.75%; Index Prime; Margin 3.50%; Floor 11.75%; ETP 4.00% | Oct 1, 2028 | — | Filing ↗ |
| Mirantis, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.8M | $3.7M | $3.7M | 99.2% | Cash rate 11.75%; Index Prime; Margin 3.50%; Floor 11.75%; ETP 4.00% | Oct 1, 2028 | — | Filing ↗ |
| Mirantis, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.8M | $3.7M | $3.7M | 99.2% | Cash rate 11.75%; Index Prime; Margin 3.50%; Floor 11.75%; ETP 4.00% | Oct 1, 2028 | — | Filing ↗ |
| Mobia Medical, Inc. fka Microtransponder, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.8M | $3.7M | $3.7M | 99.1% | Cash rate 12.25%; Index Prime; Margin 3.75%; Floor 12.25%; ETP 3.50% | Jan 1, 2029 | — | Filing ↗ |
| Mobia Medical, Inc. fka Microtransponder, Inc.Medical Device | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.8M | $3.7M | $3.7M | 99.1% | Cash rate 12.25%; Index Prime; Margin 3.75%; Floor 12.25%; ETP 3.50% | Jan 1, 2029 | — | Filing ↗ |
| GT Medical Technologies, Inc.Other Healthcare Services | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.8M | $3.7M | $3.7M | 98.9% | Cash rate 11.25%; Index Prime; Margin 3.25%; Floor 11.25%; ETP 4.00% | Oct 1, 2029 | — | Filing ↗ |
| GT Medical Technologies, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.8M | $3.7M | $3.7M | 98.9% | Cash rate 11.25%; Index Prime; Margin 3.25%; Floor 11.25%; ETP 4.00% | Oct 1, 2029 | — | Filing ↗ |
| Sonex Health, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.8M | $3.7M | $3.7M | 98.6% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 11.75%; ETP 5.00% | Apr 1, 2030 | — | Filing ↗ |
| Sonex Health, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.8M | $3.7M | $3.7M | 98.6% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 11.75%; ETP 5.00% | Apr 1, 2030 | — | Filing ↗ |
| KSQ Therapeutics, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.5M | $3.5M | $3.5M | 99.7% | Cash rate 10.75%; Index Prime; Margin 3.75%; Floor 10.75%; ETP 5.00% | Apr 1, 2030 | — | Filing ↗ |
| KSQ Therapeutics, Inc.Biotechnology | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.5M | $3.5M | $3.5M | 99.7% | Cash rate 10.75%; Index Prime; Margin 3.75%; Floor 10.75%; ETP 5.00% | Apr 1, 2030 | — | Filing ↗ |
| KSQ Therapeutics, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.5M | $3.5M | $3.5M | 99.7% | Cash rate 10.75%; Index Prime; Margin 3.75%; Floor 10.75%; ETP 5.00% | Apr 1, 2030 | — | Filing ↗ |
| KSQ Therapeutics, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.5M | $3.5M | $3.5M | 99.7% | Cash rate 10.75%; Index Prime; Margin 3.75%; Floor 10.75%; ETP 5.00% | Apr 1, 2030 | — | Filing ↗ |
| Havenly, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan (17) | $3.4M | $1.9M | $3.4M | 99.9% | Cash rate 10.50%; Index Prime; Margin 3.50%; Floor 10.50%; ETP 12.56% | Feb 1, 2028 | — | Filing ↗ |
| Supply Network Visibility Holdings LLC | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.4M | $3.4M | $3.1M | 91.4% | Cash rate 12.00%; Index Prime; Margin 4.25%; Floor 12.00%; ETP 2.50% | Jun 1, 2028 | — | Filing ↗ |
| Hometeam Technologies, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $4.8M | $4.8M | $3M | 62.2% | Cash rate 11.25%; Index Prime; Margin 3.25%; Floor 11.25%; ETP 3.50% | Aug 1, 2029 | — | Filing ↗ |
| Hometeam Technologies, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $4.8M | $4.8M | $3M | 62.2% | Cash rate 11.25%; Index Prime; Margin 3.25%; Floor 11.25%; ETP 3.50% | Aug 1, 2029 | — | Filing ↗ |
| Hometeam Technologies, Inc.Other Healthcare Services | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $4.8M | $4.8M | $3M | 62.2% | Cash rate 11.25%; Index Prime; Margin 3.25%; Floor 11.25%; ETP 3.50% | Aug 1, 2029 | — | Filing ↗ |
| Hometeam Technologies, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $4.8M | $4.8M | $3M | 62.2% | Cash rate 11.25%; Index Prime; Margin 3.25%; Floor 11.25%; ETP 3.50% | Aug 1, 2029 | — | Filing ↗ |
| Hometeam Technologies, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $4.8M | $4.8M | $3M | 62.2% | Cash rate 11.25%; Index Prime; Margin 3.25%; Floor 11.25%; ETP 3.50% | Aug 1, 2029 | — | Filing ↗ |
| HappyCo, Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3M | $3M | $3M | 99.1% | Cash rate 11.13%; Index Prime; Margin 3.75%; Floor 11.00%; ETP 2.75% | Feb 1, 2030 | — | Filing ↗ |
| HappyCo, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3M | $3M | $3M | 99.1% | Cash rate 11.13%; Index Prime; Margin 3.75%; Floor 11.00%; ETP 2.75% | Feb 1, 2030 | — | Filing ↗ |
| Bastille Buyer, Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3M | $2.9M | $3M | 98.5% | Cash rate 9.16%; Index 3-monthSOFR; Margin 5.50%; Floor 6.25% | Apr 30, 2032 | — | Filing ↗ |
| Dropoff, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $5M | $5M | $2.9M | 58.8% | Cash rate 0.00%; Margin -%; Floor -%; ETP -% | Jun 30, 2028 | — | Filing ↗ |
| Havenly, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.8M | $2.8M | $2.8M | 99.9% | Cash rate 10.50%; Index Prime; Margin 3.50%; Floor 10.50%; ETP 12.56% | Feb 1, 2028 | — | Filing ↗ |
| Havenly, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.8M | $2.8M | $2.8M | 99.9% | Cash rate 10.50%; Index Prime; Margin 3.50%; Floor 10.50%; ETP 12.56% | Feb 1, 2028 | — | Filing ↗ |
| Conventus Orthopaedics, Inc.Medical Device | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.8M | $2.8M | $2.8M | 100.0% | Cash rate 13.07%; Index Prime; Margin 6.32%; Floor 10.75%; ETP 10.88% | Jul 1, 2026 | — | Filing ↗ |
| Conventus Orthopaedics, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.8M | $2.8M | $2.8M | 100.0% | Cash rate 13.07%; Index Prime; Margin 6.32%; Floor 10.75%; ETP 10.88% | Jul 1, 2026 | — | Filing ↗ |
| MML US, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.6M | $2.6M | $2.6M | 99.2% | Cash rate 10.00%; Index Prime; Margin 3.00%; Floor 10.00%; Ceiling 13.50%; ETP 3.00% | Mar 1, 2030 | — | Filing ↗ |
| MML US, Inc.Medical Device | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.6M | $2.5M | $2.5M | 97.3% | Cash rate 10.00%; Index Prime; Margin 3.00%; Floor 10.00%; Ceiling 13.50%; ETP 3.00% | Mar 1, 2030 | — | Filing ↗ |
| Samba TV, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.5M | $2.5M | $2.5M | 98.7% | Cash rate 10.25%; Index Prime; Margin 3.50%; Floor 3.50%; ETP 4.00% | Dec 1, 2030 | — | Filing ↗ |
| Ossio, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.5M | $2.5M | $2.5M | 98.6% | Cash rate 10.00%; Index Prime; Margin 3.25%; Floor 3.25%; ETP 3.00% | Jan 20, 2031 | — | Filing ↗ |
| Spineology, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.5M | $2.5M | $2.5M | 99.0% | Cash rate 12.00%; Index Prime; Margin 5.00%; Floor 12.00%; ETP 1.00% | Aug 1, 2029 | — | Filing ↗ |
| BriteCore Holdings, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.5M | $2.5M | $2.5M | 98.9% | Cash rate 10.50%; Index Prime; Margin 3.75%; Floor 10.25%; ETP 3.00% | Jan 1, 2031 | — | Filing ↗ |
| Avive Solutions, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.5M | $2.5M | $2.5M | 98.6% | Cash rate 9.75%; Index Prime; Margin 3.00%; Floor 9.50%; ETP 3.00% | Apr 1, 2031 | — | Filing ↗ |
| Avive Solutions, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.5M | $2.5M | $2.5M | 98.6% | Cash rate 9.75%; Index Prime; Margin 3.00%; Floor 9.50%; ETP 3.00% | Apr 1, 2031 | — | Filing ↗ |
| Avive Solutions, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.5M | $2.5M | $2.5M | 98.6% | Cash rate 9.75%; Index Prime; Margin 3.00%; Floor 9.50%; ETP 3.00% | Apr 1, 2031 | — | Filing ↗ |
| Avive Solutions, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.5M | $2.5M | $2.5M | 98.6% | Cash rate 9.75%; Index Prime; Margin 3.00%; Floor 9.50%; ETP 3.00% | Apr 1, 2031 | — | Filing ↗ |
| Sonex Health, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.5M | $2.5M | $2.5M | 98.6% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 11.75%; ETP 5.00% | Apr 1, 2030 | — | Filing ↗ |
| Sonex Health, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.5M | $2.5M | $2.5M | 98.6% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 11.75%; ETP 5.00% | Apr 1, 2030 | — | Filing ↗ |
| Infobionic, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.5M | $2.4M | $2.4M | 97.6% | Cash rate 12.00%; Index Prime; Margin 5.00%; Floor 12.00%; ETP 4.00% | Sep 1, 2029 | — | Filing ↗ |
| Infobionic, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.5M | $2.4M | $2.4M | 96.6% | Cash rate 12.00%; Index Prime; Margin 5.00%; Floor 12.00%; ETP 4.00% | Sep 1, 2029 | — | Filing ↗ |
| BrightInsight, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.2M | $3.2M | $2.4M | 74.7% | Cash rate 12.50%; Index Prime; Margin 5.50%; Floor 9.50%; ETP 4.00% | Aug 1, 2027 | — | Filing ↗ |
| BrightInsight, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.2M | $3.2M | $2.4M | 74.7% | Cash rate 12.50%; Index Prime; Margin 5.50%; Floor 9.50%; ETP 4.00% | Aug 1, 2027 | — | Filing ↗ |
| Supply Network Visibility Holdings LLCSoftware | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.4M | $2.4M | $2.2M | 91.3% | Cash rate 12.00%; Index Prime; Margin 4.25%; Floor 12.00%; ETP 2.50% | Jun 1, 2028 | — | Filing ↗ |
| Supply Network Visibility Holdings LLC | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.4M | $2.4M | $2.2M | 91.3% | Cash rate 12.00%; Index Prime; Margin 4.25%; Floor 12.00%; ETP 2.50% | Jun 1, 2028 | — | Filing ↗ |
| Ursa Space Systems, Inc.Software | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.2M | $2.2M | $2.2M | 98.7% | Cash rate 12.00%; Index Prime; Margin 4.00%; Floor 12.00%; ETP 3.00% | Nov 1, 2028 | — | Filing ↗ |
| Ursa Space Systems, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.2M | $2.2M | $2.2M | 98.7% | Cash rate 12.00%; Index Prime; Margin 4.00%; Floor 12.00%; ETP 3.00% | Nov 1, 2028 | — | Filing ↗ |
| Ursa Space Systems, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.2M | $2.2M | $2.2M | 98.2% | Cash rate 12.00%; Index Prime; Margin 4.00%; Floor 12.00%; ETP 3.00% | Nov 1, 2028 | — | Filing ↗ |
| Ursa Space Systems, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.2M | $2.2M | $2.2M | 98.2% | Cash rate 12.00%; Index Prime; Margin 4.00%; Floor 12.00%; ETP 3.00% | Nov 1, 2028 | — | Filing ↗ |
| Infobionic, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.5M | $2.2M | $2.2M | 86.1% | Cash rate 12.00%; Index Prime; Margin 5.00%; Floor 12.00%; ETP 4.00% | Sep 1, 2029 | — | Filing ↗ |
| BrightInsight, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.8M | $2.7M | $2M | 74.4% | Cash rate 12.50%; Index Prime; Margin 5.50%; Floor 9.50%; ETP 4.00% | Aug 1, 2027 | — | Filing ↗ |
| HappyCo, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2M | $2M | $2M | 99.1% | Cash rate 11.13%; Index Prime; Margin 3.75%; Floor 11.00%; ETP 2.75% | Feb 1, 2030 | — | Filing ↗ |
| HappyCo, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2M | $2M | $2M | 99.0% | Cash rate 11.13%; Index Prime; Margin 3.75%; Floor 11.00%; ETP 2.75% | Feb 1, 2030 | — | Filing ↗ |
| Crafty Holdings, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2M | $2M | $2M | 98.7% | Cash rate 12.00%; Index Prime; Margin 4.50%; Floor 12.00%; ETP 4.00% | Jan 1, 2029 | — | Filing ↗ |
| BrightInsight, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan (17) | $2.3M | $1.3M | $1.7M | 74.8% | Cash rate 12.50%; Index Prime; Margin 5.50%; Floor 9.50%; ETP 4.00% | Aug 1, 2027 | — | Filing ↗ |
| Havenly, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $1.7M | $1.6M | $1.6M | 95.4% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 5.00%; ETP 16.79% | Mar 1, 2027 | — | Filing ↗ |
| Lyrical Foods, Inc.Consumer-related Technologies | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $2.7M | $2.8M | $1.5M | 57.8% | Cash rate 10.25%; Index Prime; Margin 3.50%; Floor 9.00%; ETP 5.00% | Jul 1, 2028 | — | Filing ↗ |
| Lyrical Foods, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan (17) | $2.7M | $1.3M | $1.5M | 55.9% | Cash rate 10.25%; Index Prime; Margin 3.50%; Floor 9.00%; ETP 5.00% | Jul 1, 2028 | — | Filing ↗ |
| Crafty Holdings, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $1.5M | $1.5M | $1.5M | 98.1% | Cash rate 12.00%; Index Prime; Margin 4.50%; Floor 12.00%; ETP 4.00% | Jan 1, 2029 | — | Filing ↗ |
| Supply Network Visibility Holdings LLC | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $1.4M | $1.4M | $1.3M | 91.3% | Cash rate 12.00%; Index Prime; Margin 4.25%; Floor 12.00%; ETP 2.50% | Jun 1, 2028 | — | Filing ↗ |
| Dropoff, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $1.9M | $1.9M | $1.1M | 58.8% | Cash rate 13.25%; Index Prime; Margin 6.50%; Floor 9.75%; ETP 3.50% | Jun 30, 2028 | — | Filing ↗ |
| Havenly, Inc.Consumer-related Technologies | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $1.1M | $1.1M | $1.1M | 95.1% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 5.00%; ETP 16.79% | Mar 1, 2027 | — | Filing ↗ |
| Phigenics Holdings, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $1M | $988K | $988K | 98.8% | Cash rate 8.89%; Index 1-month SOFR; Margin 5.25%; Floor 6.25% | Jun 18, 2032 | — | Filing ↗ |
| NextCar Holding Company, Inc.Consumer-related Technologies | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $1.9M | $1.9M | $936K | 50.0% | Cash rate 10.00%; Index Fixed; Margin 0.00%; Floor 0.00% | Mar 31, 2026 | — | Filing ↗ |
| Phigenics Holdings, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $839K | $830K | $838K | 99.9% | Cash rate 11.16%; Index 3-monthSOFR; Margin 7.50%; Floor 3.00% | May 15, 2028 | — | Filing ↗ |
| Provivi, Inc.Biotechnology | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $1.6M | $1.3M | $795K | 49.0% | Cash rate 12.11%; Index Prime; Margin 5.36%; Floor 9.50%; ETP 4.30% | Jan 1, 2027 | — | Filing ↗ |
| Provivi, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $1.6M | $1.3M | $795K | 49.0% | Cash rate 12.11%; Index Prime; Margin 5.36%; Floor 9.50%; ETP 4.30% | Jan 1, 2027 | — | Filing ↗ |
| Shengrow, Inc. aka Soli Organic, Inc.Other Sustainability | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan (17) | $5.6M | $636K | $561K | 10.1% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 11.75%; ETP 2.75% | Sep 1, 2028 | — | Filing ↗ |
| Provivi, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $811K | $649K | $397K | 49.0% | Cash rate 12.11%; Index Prime; Margin 5.36%; Floor 9.50%; ETP 4.31% | Jan 1, 2027 | — | Filing ↗ |
| Provivi, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $811K | $649K | $397K | 49.0% | Cash rate 12.11%; Index Prime; Margin 5.36%; Floor 9.50%; ETP 4.31% | Jan 1, 2027 | — | Filing ↗ |
| Provivi, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $811K | $649K | $397K | 49.0% | Cash rate 12.11%; Index Prime; Margin 5.36%; Floor 9.50%; ETP 4.31% | Jan 1, 2027 | — | Filing ↗ |
| Provivi, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $811K | $649K | $396K | 48.8% | Cash rate 12.11%; Index Prime; Margin 5.36%; Floor 9.50%; ETP 4.31% | Jan 1, 2027 | — | Filing ↗ |
| Shengrow, Inc. aka Soli Organic, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.7M | $3.6M | $370K | 10.0% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 11.75%; ETP 2.75% | Sep 1, 2028 | — | Filing ↗ |
| Shengrow, Inc. aka Soli Organic, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.7M | $3.6M | $370K | 10.0% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 11.75%; ETP 2.75% | Sep 1, 2028 | — | Filing ↗ |
| Shengrow, Inc. aka Soli Organic, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $3.7M | $3.6M | $370K | 10.0% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 11.75%; ETP 2.75% | Sep 1, 2028 | — | Filing ↗ |
| Shengrow, Inc. aka Soli Organic, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $1.9M | $1.8M | $185K | 10.0% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 11.75%; ETP 2.75% | Sep 1, 2028 | — | Filing ↗ |
| Shengrow, Inc. aka Soli Organic, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $1.9M | $1.8M | $185K | 10.0% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 11.75%; ETP 2.75% | Sep 1, 2028 | — | Filing ↗ |
| Shengrow, Inc. aka Soli Organic, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $1.9M | $1.8M | $185K | 10.0% | Cash rate 11.75%; Index Prime; Margin 5.00%; Floor 11.75%; ETP 2.75% | Sep 1, 2028 | — | Filing ↗ |
| Nexii, Inc.Other Sustainability | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan | $790K | $833K | $0 | 0.0% | Cash rate 10.00%; Index Fixed; Margin 0.00%; Floor 0.00% | Jul 1, 2027 | — | Filing ↗ |
| Nexii, Inc. | senior secured loanLevel 3 debt: discounted cash flows / probability-weighted expected cash flow or return methods; asset-class disclosure, individual model variant not identified. — Term Loan (17) | $304K | $173K | $0 | 0.0% | Cash rate 10.00%; Index Fixed; Margin 0.00%; Floor 0.00% | Jul 1, 2027 | — | Filing ↗ |
Schedule of investments
Warrant & equity positions
Jun 30, 2026 reporting period
| Company | Fair value | % of NAV | Security | Implied price / share | Methodology / source |
|---|---|---|---|---|---|
| Hound Labs II, LLCDiagnostics | $3.8MJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $799.12Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Havenly, Inc.Consumer-related Technologies | $3.2MJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $1.98Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Aerobiotix, LLCMedical Device | $1.7MJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | —Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Kodiak Robotics, Inc.Software | $1.7MJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $5.08Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Infobionic, Inc.Medical Device | $1.7MJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.18Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Evelo Holdings, Inc.Biotechnology | $1.5MJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | —Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Mirantis, Inc.Software | $1.4MJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $1.50Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Aerin Medical, Inc.Medical Device | $1.3MJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.74Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Intelepeer Holdings, Inc.Communications | $1.3MJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.43Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Ceribell, Inc.Medical Device | $997KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $11.09Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Cognoa, Inc.Medical Device | $975KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.06Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Divergent Technologies, Inc.Consumer-related Technologies | $770KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $10.84Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Xeris Pharmaceuticals, Inc.Biotechnology | $701KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $5.56Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| BriteCore Holdings, Inc.Software | $509KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $2.62Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Pelthos Therapeutics, Inc.Biotechnology | $507KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $7.74Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Cognoa, Inc.Medical Device | $500KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.24Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| CSA Medical, Inc.Medical Device | $474KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.10Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Emalex Biosciences, Inc.Biotechnology | $457KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | —Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Lumithera, Inc.Medical Device | $351KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | —Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Sonex Health, Inc.Medical Device | $337KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.06Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Viken Detection CorporationSoftware | $337KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.98Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Axiom Space Holdings, Inc.Communications | $306KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $169.06Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Magnolia Medical Technologies, Inc.Medical Device | $248KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.28Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Castle Creek Biosciences, Inc.Biotechnology | $217KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $186.75Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| RoHo Capital Opportunity Fund LLC$ | $215KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | —Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Hyperfine, Inc.Medical Device | $211KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.38Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Onkos Surgical, Inc.Medical Device | $206KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.46Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| GT Medical Technologies, Inc.Other Healthcare | $201KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.62Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Crafty Holdings, Inc.Software | $188KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.69Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Castle Creek Biosciences, Inc.Biotechnology | $180KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $13.02Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Silk, Inc.Data Storage | $175KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.44Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Mobia Medical, Inc. fka Microtransponder, Inc.Medical Device | $171KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $1.66Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Ursa Space Systems, Inc.Software | $146KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.14Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Cadrenal Therapeutics, Inc.Biotechnology | $134KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $3.35Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Ossio, Inc.Medical Device | $119KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $3.49Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| VERO Biotech LLCMedical Device | $116KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $31.34Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| SafelyYou, Inc.Software | $102KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.49Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Revinate Holdings, Inc.Software | $89KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.13Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Avive Solutions, Inc.Medical Device | $88KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.06Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Meditrina, Inc.Medical Device | $84KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.36Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Rocket Lawyer IncorporatedInternet and Media | $78KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.30Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Lemongrass Holdings, Inc.Software | $76KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.38Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| KSQ Therapeutics, Inc.Biotechnology | $74KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.55Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| PebblePost, Inc.Communications | $73KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $1.30Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Apkudo, Inc.Software | $64KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $2.01Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Divergent Technologies, Inc.Consumer-related Technologies | $61KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $4.67Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| MyForest Foods Co.Consumer-related Technologies | $49KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $98.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Slingshot Aerospace, Inc.Software | $47KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.15Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| HappyCo, Inc.Software | $45KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.47Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| LiquiGlide, Inc.Other Sustainability | $43KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.35Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Clara Foods Co.Consumer-related Technologies | $43KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.92Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Stellar Cyber, Inc.Software | $40KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.22Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Axiom Space Holdings, Inc.Communications | $39KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $14.69Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Temperpack Technologies, Inc.Other Sustainability | $29KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.44Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Spineology, Inc.Medical Device | $23KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.51Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| CPG Beyond, Inc.Data Storage | $22KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.04Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Primary Kids, Inc.Consumer-related Technologies | $21KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.04Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Tigo Energy, Inc.Other Sustainability | $12KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $2.31Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| BioVaxys Technology Corp.Biotechnology | $8KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.12Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Stealth Biotherapeutics Inc.Biotechnology | $7KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.02Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Native Microbials, IncBiotechnology | $5KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.03Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| CVRx, Inc.Medical Device | $4KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.08Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Cognoa, Inc.Medical Device | $4KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.07Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Pivot Bio, Inc.Energy Efficiency | $3KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.01Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| OneNetworks, Inc.Software | $3KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.02Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Cognoa, Inc.Medical Device | $2KJun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Decisyon, Inc.Software | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| SnagAJob.com, Inc.Consumer-related Technologies | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| BioVaxys Technology Corp.Biotechnology | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | —Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Better Place Forests Co.Consumer-related Technologies | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | —Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| BrightInsight, Inc.Software | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Elligo Health Research, Inc.Software | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Avalo Therapeutics, Inc.Biotechnology | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| BioVaxys Technology Corp.Biotechnology | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Canary Medical Inc.Medical Device | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Conventus Orthopaedics, Inc.Medical Device | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Imunon, Inc.Biotechnology | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Mustang Bio, Inc.Biotechnology | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| PDS Biotechnology CorporationBiotechnology | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Provivi, Inc.Biotechnology | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Provivi, Inc.Biotechnology | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Spineology, Inc.Medical Device | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Tallac Therapeutics, Inc.Medical Device | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | —Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| ZetrOz, Inc.Medical Device | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | —Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Alula Holdings, Inc.Consumer-related Technologies | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| CAMP NYC, Inc.Consumer-related Technologies | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Dropoff, Inc.Software | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Everstream Holdings, LLCSoftware | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Global Worldwide LLCInternet and Media | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Liqid, Inc.Networking | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Noodle Partners, Inc.Software | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Quip NYC Inc.Consumer-related Technologies | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| SIGNiX, Inc.Software | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Skillshare, Inc.Internet and Media | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Supply Network Visibility Holdings LLCSoftware | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Topia Mobility, Inc.Software | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Updater, Inc.Consumer-related Technologies | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Aulea Medical, Inc.Medical Device | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Evelo Holdings, Inc.Biotechnology | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Nexii, Inc.Other Sustainability | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| NextCar Holding Company, Inc.Consumer-related Technologies | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Shengrow, Inc. aka Soli Organic, Inc.Other Sustainability | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Shengrow, Inc. aka Soli Organic, Inc.Other Sustainability | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
| Evelo Holdings, Inc.Biotechnology | $0Jun 30, 2026 · source ↗ | —Jun 30, 2026 · source ↗ | warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. | $0.00Jun 30, 2026 · source ↗ | 10-Q 2026-06-30 ↗ |
Position history
Reported fair-value marks
Each bar is a disclosed position-quarter.
$215KRoHo Capital Opportunity Fund LLCJun 30, 2026 · source ↗$2MBrightInsight, Inc.Jun 30, 2026 · source ↗$2.4MBrightInsight, Inc.Jun 30, 2026 · source ↗$4.1MBrightInsight, Inc.Jun 30, 2026 · source ↗$1.7MBrightInsight, Inc.Jun 30, 2026 · source ↗$2.4MBrightInsight, Inc.Jun 30, 2026 · source ↗$4.8MBrightInsight, Inc.Jun 30, 2026 · source ↗$5MElligo Health Research, Inc.Jun 30, 2026 · source ↗$9.9MElligo Health Research, Inc.Jun 30, 2026 · source ↗$5MElligo Health Research, Inc.Jun 30, 2026 · source ↗$5MElligo Health Research, Inc.Jun 30, 2026 · source ↗$3.7MGT Medical Technologies, Inc.Jun 30, 2026 · source ↗$7.4MGT Medical Technologies, Inc.Jun 30, 2026 · source ↗$3.7MGT Medical Technologies, Inc.Jun 30, 2026 · source ↗$3MHometeam Technologies, Inc.Jun 30, 2026 · source ↗$3MHometeam Technologies, Inc.Jun 30, 2026 · source ↗$3MHometeam Technologies, Inc.Jun 30, 2026 · source ↗$3MHometeam Technologies, Inc.Jun 30, 2026 · source ↗$3MHometeam Technologies, Inc.Jun 30, 2026 · source ↗$2.5MAvive Solutions, Inc.Jun 30, 2026 · source ↗$2.5MAvive Solutions, Inc.Jun 30, 2026 · source ↗$4.9MAvive Solutions, Inc.Jun 30, 2026 · source ↗$2.5MAvive Solutions, Inc.Jun 30, 2026 · source ↗$2.5MAvive Solutions, Inc.Jun 30, 2026 · source ↗$4.9MAvive Solutions, Inc.Jun 30, 2026 · source ↗$5MCastle Creek Biosciences, Inc.Jun 30, 2026 · source ↗$10MCastle Creek Biosciences, Inc.Jun 30, 2026 · source ↗$5MCastle Creek Biosciences, Inc.Jun 30, 2026 · source ↗$5.5MCastle Creek Biosciences, Inc.Jun 30, 2026 · source ↗$5MCeribell, Inc.Jun 30, 2026 · source ↗$4.9MCeribell, Inc.Jun 30, 2026 · source ↗$4MCeribell, Inc.Jun 30, 2026 · source ↗$2.8MConventus Orthopaedics, Inc.Jun 30, 2026 · source ↗$2.8MConventus Orthopaedics, Inc.Jun 30, 2026 · source ↗$4.6MHyperfine, Inc.Jun 30, 2026 · source ↗$4.9MHyperfine, Inc.Jun 30, 2026 · source ↗$4.9MHyperfine, Inc.Jun 30, 2026 · source ↗$2.4MInfobionic, Inc.Jun 30, 2026 · source ↗$2.2MInfobionic, Inc.Jun 30, 2026 · source ↗$4.9MInfobionic, Inc.Jun 30, 2026 · source ↗$4.9MInfobionic, Inc.Jun 30, 2026 · source ↗$4.9MInfobionic, Inc.Jun 30, 2026 · source ↗$3.5MKSQ Therapeutics, Inc.Jun 30, 2026 · source ↗$3.5MKSQ Therapeutics, Inc.Jun 30, 2026 · source ↗$3.5MKSQ Therapeutics, Inc.Jun 30, 2026 · source ↗$3.5MKSQ Therapeutics, Inc.Jun 30, 2026 · source ↗$10.5MLong Grove Pharmaceuticals, LLCJun 30, 2026 · source ↗$5.2MMML US, Inc.Jun 30, 2026 · source ↗$5.2MMML US, Inc.Jun 30, 2026 · source ↗$2.5MMML US, Inc.Jun 30, 2026 · source ↗$5.1MMML US, Inc.Jun 30, 2026 · source ↗$2.6MMML US, Inc.Jun 30, 2026 · source ↗$3.7MMobia Medical, Inc. fka Microtransponder, Inc.Jun 30, 2026 · source ↗$3.7MMobia Medical, Inc. fka Microtransponder, Inc.Jun 30, 2026 · source ↗$2.4MInfobionic, Inc.Jun 30, 2026 · source ↗$9.9MOnkos Surgical, Inc.Jun 30, 2026 · source ↗$5MMML US, Inc.Jun 30, 2026 · source ↗$9.9MOnkos Surgical, Inc.Jun 30, 2026 · source ↗$5MMML US, Inc.Jun 30, 2026 · source ↗$5.1MMML US, Inc.Jun 30, 2026 · source ↗$12.4MOssio, Inc.Jun 30, 2026 · source ↗$4.9MOnkos Surgical, Inc.Jun 30, 2026 · source ↗$4.9MOnkos Surgical, Inc.Jun 30, 2026 · source ↗$4.9MPelthos Therapeutics, Inc.Jun 30, 2026 · source ↗$9.8MPelthos Therapeutics, Inc.Jun 30, 2026 · source ↗$4.9MPelthos Therapeutics, Inc.Jun 30, 2026 · source ↗$9.8MPelthos Therapeutics, Inc.Jun 30, 2026 · source ↗$397KProvivi, Inc.Jun 30, 2026 · source ↗$397KProvivi, Inc.Jun 30, 2026 · source ↗$795KProvivi, Inc.Jun 30, 2026 · source ↗$396KProvivi, Inc.Jun 30, 2026 · source ↗$397KProvivi, Inc.Jun 30, 2026 · source ↗$795KProvivi, Inc.Jun 30, 2026 · source ↗$2.5MOssio, Inc.Jun 30, 2026 · source ↗$7.5MOssio, Inc.Jun 30, 2026 · source ↗$4.9MOnkos Surgical, Inc.Jun 30, 2026 · source ↗$2.5MSonex Health, Inc.Jun 30, 2026 · source ↗$3.7MSonex Health, Inc.Jun 30, 2026 · source ↗$9.8MSonex Health, Inc.Jun 30, 2026 · source ↗$2.5MSonex Health, Inc.Jun 30, 2026 · source ↗$3.7MSonex Health, Inc.Jun 30, 2026 · source ↗$9.9MSonex Health, Inc.Jun 30, 2026 · source ↗$2.5MSpineology, Inc.Jun 30, 2026 · source ↗$4.9MSpineology, Inc.Jun 30, 2026 · source ↗$4.2MSpineology, Inc.Jun 30, 2026 · source ↗$4.2MSpineology, Inc.Jun 30, 2026 · source ↗$4.9MPhigenics Holdings, Inc.Jun 30, 2026 · source ↗$988KPhigenics Holdings, Inc.Jun 30, 2026 · source ↗$4.9MApkudo, Inc.Jun 30, 2026 · source ↗$4.9MApkudo, Inc.Jun 30, 2026 · source ↗$3MBastille Buyer, Inc.Jun 30, 2026 · source ↗$9.8MBriteCore Holdings, Inc.Jun 30, 2026 · source ↗$2.5MBriteCore Holdings, Inc.Jun 30, 2026 · source ↗$7.4MBriteCore Holdings, Inc.Jun 30, 2026 · source ↗$1.5MCrafty Holdings, Inc.Jun 30, 2026 · source ↗$2MCrafty Holdings, Inc.Jun 30, 2026 · source ↗$4.9MCrafty Holdings, Inc.Jun 30, 2026 · source ↗$4.9MCrafty Holdings, Inc.Jun 30, 2026 · source ↗$4.9MCrafty Holdings, Inc.Jun 30, 2026 · source ↗$2.9MDropoff, Inc.Jun 30, 2026 · source ↗$4.8MDropoff, Inc.Jun 30, 2026 · source ↗$5.4MDropoff, Inc.Jun 30, 2026 · source ↗$1.1MDropoff, Inc.Jun 30, 2026 · source ↗$838KPhigenics Holdings, Inc.Jun 30, 2026 · source ↗$2MHappyCo, Inc.Jun 30, 2026 · source ↗$3MHappyCo, Inc.Jun 30, 2026 · source ↗$2MHappyCo, Inc.Jun 30, 2026 · source ↗$3MHappyCo, Inc.Jun 30, 2026 · source ↗$2.8MHavenly, Inc.Jun 30, 2026 · source ↗$2.8MHavenly, Inc.Jun 30, 2026 · source ↗$1.1MHavenly, Inc.Jun 30, 2026 · source ↗$3.4MHavenly, Inc.Jun 30, 2026 · source ↗$1.6MHavenly, Inc.Jun 30, 2026 · source ↗$5MHiveMQ Inc.Jun 30, 2026 · source ↗$5MHiveMQ Inc.Jun 30, 2026 · source ↗$4.8MHiveMQ Inc.Jun 30, 2026 · source ↗$5MHiveMQ Inc.Jun 30, 2026 · source ↗$5MHiveMQ Inc.Jun 30, 2026 · source ↗$14.6MKodiak Robotics, Inc.Jun 30, 2026 · source ↗$7.3MKodiak Robotics, Inc.Jun 30, 2026 · source ↗$7.3MKodiak Robotics, Inc.Jun 30, 2026 · source ↗$1.5MLyrical Foods, Inc.Jun 30, 2026 · source ↗$1.5MLyrical Foods, Inc.Jun 30, 2026 · source ↗$7.4MMasteryPrep, LLCJun 30, 2026 · source ↗$7.4MMasteryPrep, LLCJun 30, 2026 · source ↗$3.7MMirantis, Inc.Jun 30, 2026 · source ↗$3.7MMirantis, Inc.Jun 30, 2026 · source ↗$3.7MMirantis, Inc.Jun 30, 2026 · source ↗$3.7MMirantis, Inc.Jun 30, 2026 · source ↗$2.5MSamba TV, Inc.Jun 30, 2026 · source ↗$9.9MSamba TV, Inc.Jun 30, 2026 · source ↗$5MSamba TV, Inc.Jun 30, 2026 · source ↗$7.4MSamba TV, Inc.Jun 30, 2026 · source ↗$4.8MStellar Cyber, Inc.Jun 30, 2026 · source ↗$4.9MStellar Cyber, Inc.Jun 30, 2026 · source ↗$4.9MStellar Cyber, Inc.Jun 30, 2026 · source ↗$4.6MSupply Network Visibility Holdings LLCJun 30, 2026 · source ↗$1.3MSupply Network Visibility Holdings LLCJun 30, 2026 · source ↗$2.2MSupply Network Visibility Holdings LLCJun 30, 2026 · source ↗$2.2MSupply Network Visibility Holdings LLCJun 30, 2026 · source ↗$3.1MSupply Network Visibility Holdings LLCJun 30, 2026 · source ↗$2.2MUrsa Space Systems, Inc.Jun 30, 2026 · source ↗$2.2MUrsa Space Systems, Inc.Jun 30, 2026 · source ↗$2.2MUrsa Space Systems, Inc.Jun 30, 2026 · source ↗$2.2MUrsa Space Systems, Inc.Jun 30, 2026 · source ↗$4MVolt Bidco, Inc.Jun 30, 2026 · source ↗$306KAxiom Space Holdings, Inc.Jun 30, 2026 · source ↗$8KBioVaxys Technology Corp.Jun 30, 2026 · source ↗$134KCadrenal Therapeutics, Inc.Jun 30, 2026 · source ↗$217KCastle Creek Biosciences, Inc.Jun 30, 2026 · source ↗$975KCognoa, Inc.Jun 30, 2026 · source ↗$500KCognoa, Inc.Jun 30, 2026 · source ↗$0Decisyon, Inc.Jun 30, 2026 · source ↗$457KEmalex Biosciences, Inc.Jun 30, 2026 · source ↗$1.7MKodiak Robotics, Inc.Jun 30, 2026 · source ↗$73KPebblePost, Inc.Jun 30, 2026 · source ↗$0SnagAJob.com, Inc.Jun 30, 2026 · source ↗$12KTigo Energy, Inc.Jun 30, 2026 · source ↗$1.7MAerobiotix, LLCJun 30, 2026 · source ↗$0BioVaxys Technology Corp.Jun 30, 2026 · source ↗$351KLumithera, Inc.Jun 30, 2026 · source ↗$0Better Place Forests Co.Jun 30, 2026 · source ↗$0BrightInsight, Inc.Jun 30, 2026 · source ↗$0Elligo Health Research, Inc.Jun 30, 2026 · source ↗$201KGT Medical Technologies, Inc.Jun 30, 2026 · source ↗$102KSafelyYou, Inc.Jun 30, 2026 · source ↗$1.3MAerin Medical, Inc.Jun 30, 2026 · source ↗$0Avalo Therapeutics, Inc.Jun 30, 2026 · source ↗$88KAvive Solutions, Inc.Jun 30, 2026 · source ↗$0BioVaxys Technology Corp.Jun 30, 2026 · source ↗$474KCSA Medical, Inc.Jun 30, 2026 · source ↗$4KCVRx, Inc.Jun 30, 2026 · source ↗$0Canary Medical Inc.Jun 30, 2026 · source ↗$180KCastle Creek Biosciences, Inc.Jun 30, 2026 · source ↗$997KCeribell, Inc.Jun 30, 2026 · source ↗$4KCognoa, Inc.Jun 30, 2026 · source ↗$2KCognoa, Inc.Jun 30, 2026 · source ↗$0Conventus Orthopaedics, Inc.Jun 30, 2026 · source ↗$211KHyperfine, Inc.Jun 30, 2026 · source ↗$0Imunon, Inc.Jun 30, 2026 · source ↗$1.7MInfobionic, Inc.Jun 30, 2026 · source ↗$74KKSQ Therapeutics, Inc.Jun 30, 2026 · source ↗$248KMagnolia Medical Technologies, Inc.Jun 30, 2026 · source ↗$84KMeditrina, Inc.Jun 30, 2026 · source ↗$171KMobia Medical, Inc. fka Microtransponder, Inc.Jun 30, 2026 · source ↗$0Mustang Bio, Inc.Jun 30, 2026 · source ↗$5KNative Microbials, IncJun 30, 2026 · source ↗$206KOnkos Surgical, Inc.Jun 30, 2026 · source ↗$119KOssio, Inc.Jun 30, 2026 · source ↗$0PDS Biotechnology CorporationJun 30, 2026 · source ↗$507KPelthos Therapeutics, Inc.Jun 30, 2026 · source ↗$0Provivi, Inc.Jun 30, 2026 · source ↗$0Provivi, Inc.Jun 30, 2026 · source ↗$337KSonex Health, Inc.Jun 30, 2026 · source ↗$0Spineology, Inc.Jun 30, 2026 · source ↗$23KSpineology, Inc.Jun 30, 2026 · source ↗$7KStealth Biotherapeutics Inc.Jun 30, 2026 · source ↗$0Tallac Therapeutics, Inc.Jun 30, 2026 · source ↗$116KVERO Biotech LLCJun 30, 2026 · source ↗$701KXeris Pharmaceuticals, Inc.Jun 30, 2026 · source ↗$0ZetrOz, Inc.Jun 30, 2026 · source ↗$43KLiquiGlide, Inc.Jun 30, 2026 · source ↗$3KPivot Bio, Inc.Jun 30, 2026 · source ↗$29KTemperpack Technologies, Inc.Jun 30, 2026 · source ↗$0Alula Holdings, Inc.Jun 30, 2026 · source ↗$64KApkudo, Inc.Jun 30, 2026 · source ↗$39KAxiom Space Holdings, Inc.Jun 30, 2026 · source ↗$509KBriteCore Holdings, Inc.Jun 30, 2026 · source ↗$0CAMP NYC, Inc.Jun 30, 2026 · source ↗$22KCPG Beyond, Inc.Jun 30, 2026 · source ↗$43KClara Foods Co.Jun 30, 2026 · source ↗$188KCrafty Holdings, Inc.Jun 30, 2026 · source ↗$61KDivergent Technologies, Inc.Jun 30, 2026 · source ↗$770KDivergent Technologies, Inc.Jun 30, 2026 · source ↗$0Dropoff, Inc.Jun 30, 2026 · source ↗$0Everstream Holdings, LLCJun 30, 2026 · source ↗$0Global Worldwide LLCJun 30, 2026 · source ↗$45KHappyCo, Inc.Jun 30, 2026 · source ↗$3.2MHavenly, Inc.Jun 30, 2026 · source ↗$1.3MIntelepeer Holdings, Inc.Jun 30, 2026 · source ↗$76KLemongrass Holdings, Inc.Jun 30, 2026 · source ↗$0Liqid, Inc.Jun 30, 2026 · source ↗$1.4MMirantis, Inc.Jun 30, 2026 · source ↗$49KMyForest Foods Co.Jun 30, 2026 · source ↗$0Noodle Partners, Inc.Jun 30, 2026 · source ↗$3KOneNetworks, Inc.Jun 30, 2026 · source ↗$21KPrimary Kids, Inc.Jun 30, 2026 · source ↗$0Quip NYC Inc.Jun 30, 2026 · source ↗$89KRevinate Holdings, Inc.Jun 30, 2026 · source ↗$78KRocket Lawyer IncorporatedJun 30, 2026 · source ↗$0SIGNiX, Inc.Jun 30, 2026 · source ↗$175KSilk, Inc.Jun 30, 2026 · source ↗$0Skillshare, Inc.Jun 30, 2026 · source ↗$47KSlingshot Aerospace, Inc.Jun 30, 2026 · source ↗$40KStellar Cyber, Inc.Jun 30, 2026 · source ↗$0Supply Network Visibility Holdings LLCJun 30, 2026 · source ↗$0Topia Mobility, Inc.Jun 30, 2026 · source ↗$0Updater, Inc.Jun 30, 2026 · source ↗$146KUrsa Space Systems, Inc.Jun 30, 2026 · source ↗$337KViken Detection CorporationJun 30, 2026 · source ↗$6.7MHound Labs II, LLCJun 30, 2026 · source ↗$0Nexii, Inc.Jun 30, 2026 · source ↗$0Nexii, Inc.Jun 30, 2026 · source ↗$936KNextCar Holding Company, Inc.Jun 30, 2026 · source ↗$5MShengrow, Inc. aka Soli Organic, Inc.Jun 30, 2026 · source ↗$5MShengrow, Inc. aka Soli Organic, Inc.Jun 30, 2026 · source ↗$185KShengrow, Inc. aka Soli Organic, Inc.Jun 30, 2026 · source ↗$370KShengrow, Inc. aka Soli Organic, Inc.Jun 30, 2026 · source ↗$561KShengrow, Inc. aka Soli Organic, Inc.Jun 30, 2026 · source ↗$185KShengrow, Inc. aka Soli Organic, Inc.Jun 30, 2026 · source ↗$370KShengrow, Inc. aka Soli Organic, Inc.Jun 30, 2026 · source ↗$185KShengrow, Inc. aka Soli Organic, Inc.Jun 30, 2026 · source ↗$370KShengrow, Inc. aka Soli Organic, Inc.Jun 30, 2026 · source ↗$0Aulea Medical, Inc.Jun 30, 2026 · source ↗$0Evelo Holdings, Inc.Jun 30, 2026 · source ↗$3.8MHound Labs II, LLCJun 30, 2026 · source ↗$0Nexii, Inc.Jun 30, 2026 · source ↗$0NextCar Holding Company, Inc.Jun 30, 2026 · source ↗$0Shengrow, Inc. aka Soli Organic, Inc.Jun 30, 2026 · source ↗$0Shengrow, Inc. aka Soli Organic, Inc.Jun 30, 2026 · source ↗$1.5MEvelo Holdings, Inc.Jun 30, 2026 · source ↗$0Evelo Holdings, Inc.Jun 30, 2026 · source ↗$4.9MGlass Routes, LLC.Jun 30, 2026 · source ↗